Mylan N.V. recently merged with Pfizer's UpJohn division to form Viatris Inc. and announced the resignation of Chief Executive Officer Heather M. Bresch, effective November 16, 2020. Ms. Bresch has been CEO since January 1, 2012. From 2012 to 2019, Bresch realized $113,565,411 in total compensation.
Michael Goettler will serve as Chief Executive Officer of the newly formed company, Viatris.
To view the details of this transition, please click here.
Heather Bresch is the 67th CEO from the Equilar 500 to announce their resignation in 2020.
Senior Research Analyst at Equilar
Brielle Ferdinand, Senior Research Analyst at Equilar, authored this post. Please contact Amit Batish, Manager, Content & Communications, at firstname.lastname@example.org for more information on Equilar research and data analysis.